Shaanxi Meibang Pharmaceutical Group Co., Ltd. (SHA:605033)

SHA:605033 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	857.58	881.01	694.02	905.41	841.93	562.54
Other Revenue	3.67	4.52	5.01	0.63	0.56	5.98
Revenue	861.25	885.53	699.03	906.05	842.49	568.52
Revenue Growth (YoY)	17.58%	26.68%	-22.85%	7.54%	48.19%	10.24%
Cost of Revenue	620.7	654.14	478.04	528.82	532.38	368.03
Gross Profit	240.55	231.39	220.99	377.23	310.11	200.49
Selling, General & Admin	152.55	141.19	119.27	153.18	116.7	61.48
Research & Development	80.91	74.33	58.53	80.04	63.81	51.36
Other Operating Expenses	8.51	2.23	2.75	3.45	2.9	2.26
Operating Expenses	233.78	212.51	178.09	242.66	187.05	115.47
Operating Income	6.77	18.88	42.9	134.57	123.06	85.02
Interest Expense	-	-0.01	-0.38	-0.98	-3.31	-0.85
Interest & Investment Income	8.38	9.33	6.58	6.86	2.61	3.51
Currency Exchange Gain (Loss)	0.01	0.02	0	-	0.06	0.01
Other Non Operating Income (Expenses)	-1.86	-0.15	-0.13	-0.11	0.08	-0.1
EBT Excluding Unusual Items	13.3	28.07	48.97	140.34	122.5	87.59
Gain (Loss) on Sale of Investments	0.11	0.47	-	-0.07	-	-
Gain (Loss) on Sale of Assets	-0.08	-0.04	-0.04	-0.12	-0.02	-0.1
Asset Writedown	0	0	0.01	-	-	-
Other Unusual Items	11.43	9.35	13.47	12.21	16.35	1.89
Pretax Income	24.77	37.86	62.41	152.37	138.83	89.39
Income Tax Expense	-0.8	1	4.85	7.28	13.09	10.65
Net Income	25.57	36.86	57.56	145.09	125.74	78.73
Net Income to Common	25.57	36.86	57.56	145.09	125.74	78.73
Net Income Growth	-18.50%	-35.96%	-60.33%	15.38%	59.70%	3.25%
Shares Outstanding (Basic)	136	137	134	136	110	101
Shares Outstanding (Diluted)	136	137	134	136	110	101
Shares Change (YoY)	1.67%	1.99%	-1.29%	22.93%	9.27%	1.93%
EPS (Basic)	0.19	0.27	0.43	1.07	1.14	0.78
EPS (Diluted)	0.19	0.27	0.43	1.07	1.14	0.78
EPS Growth	-19.84%	-37.21%	-59.81%	-6.14%	46.15%	1.30%
Free Cash Flow	8.02	121.59	131.1	17.12	-215.28	13.17
Free Cash Flow Per Share	0.06	0.89	0.98	0.13	-1.95	0.13
Dividend Per Share	0.100	0.145	0.150	0.220	0.190	-
Dividend Growth	-48.72%	-3.33%	-31.82%	15.79%	-	-
Gross Margin	27.93%	26.13%	31.61%	41.63%	36.81%	35.27%
Operating Margin	0.79%	2.13%	6.14%	14.85%	14.61%	14.95%
Profit Margin	2.97%	4.16%	8.23%	16.01%	14.92%	13.85%
Free Cash Flow Margin	0.93%	13.73%	18.75%	1.89%	-25.55%	2.32%
EBITDA	31.85	39.31	63.77	150.05	135.54	95.49
EBITDA Margin	3.70%	4.44%	9.12%	16.56%	16.09%	16.80%
D&A For EBITDA	25.08	20.43	20.87	15.47	12.48	10.47
EBIT	6.77	18.88	42.9	134.57	123.06	85.02
EBIT Margin	0.79%	2.13%	6.14%	14.85%	14.61%	14.95%
Effective Tax Rate	-	2.64%	7.78%	4.78%	9.43%	11.92%
Revenue as Reported	861.25	885.53	699.03	906.05	842.49	568.52
Advertising Expenses	-	17.2	10.78	27.33	11.56	8.17

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.